Human endokine alpha and methods of use
    3.
    发明公开
    Human endokine alpha and methods of use 审中-公开
    Menschliches alpha-Endokin und Verfahren zu seiner Verwendung

    公开(公告)号:EP2357192A1

    公开(公告)日:2011-08-17

    申请号:EP10179623.3

    申请日:2000-02-25

    CPC分类号: C07K14/5255 A61K38/00

    摘要: The present invention concerns a novel member of the tumor necrosis factor (TNF) family of cytokines. In particular, isolated nucleic acid molecules are provided encoding the endokine alpha protein. Endokine alpha polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic and therapeutic methods concerning TNF family-related disorders.

    摘要翻译: 本发明涉及细胞因子的肿瘤坏死因子(TNF)家族的新成员。 特别地,提供了分离的核酸分子,其编码内丝蛋白α蛋白。 还提供了内含子α多肽,载体,宿主细胞以及用于制备它们的重组方法也是如此。 还提供了关于TNF家族相关疾病的诊断和治疗方法。

    Cytokine immunoconjugates
    7.
    发明公开
    Cytokine immunoconjugates 失效
    细胞因子免疫粘附

    公开(公告)号:EP1149913A1

    公开(公告)日:2001-10-31

    申请号:EP01103439.4

    申请日:1991-11-07

    摘要: Immunoconjugates for the selective delivery of a cytokine to a target cell are disclosed. The immunoconjugates are comprised of an immunoglobulin heavy chain having a specificity for the target cell, such as a cancer or virus-infected cell, and a cytokine, such as lymphotoxin, tumor necrosis factor alpha, interleukin-2, or granulocyte-macrophage colony stimulating factor, joined via Aits amino terminal amino acid to the carboxy-Aterminus of the immunoglobulin. Nucleic acid sequences encoding these immunoconjugates and method of their preparation by genetic engineering techniques are also disclosed.

    摘要翻译: 公开了将细胞因子选择性递送至靶细胞的免疫偶联物。 免疫缀合物由对靶细胞如癌或病毒感染的细胞特异性的免疫球蛋白重链和细胞因子如淋巴毒素,肿瘤坏死因子α,白介素-2或粒细胞 - 巨噬细胞集落刺激组成 因子,通过Aits氨基末端氨基酸连接到免疫球蛋白的羧基末端。 还公开了编码这些免疫缀合物的核酸序列及其通过基因工程技术制备的方法。

    Lymphotoxin, nucleic acid encoding it, vectors incorporating the nucleic acid and cells transformed therewith, methods of obtaining lymphotoxin, and lymphotoxin neutralizing antibody
    9.
    发明公开
    Lymphotoxin, nucleic acid encoding it, vectors incorporating the nucleic acid and cells transformed therewith, methods of obtaining lymphotoxin, and lymphotoxin neutralizing antibody 失效
    淋巴毒素,核酸编码为此,含有该核酸的载体和由此转化的细胞,处理用于获得淋巴毒素和淋巴毒素中和抗体。

    公开(公告)号:EP0164965A2

    公开(公告)日:1985-12-18

    申请号:EP85303818.0

    申请日:1985-05-30

    申请人: GENENTECH, INC.

    摘要: Biologically active lymphotoxin polypeptides are synthesized in recombinant cell culture. Novel nucleic acid and vectors incorporating same are provided. The compositions and processes herein enable the economical preparation of compositions containing uniform lymphotoxin polypeptides and variant lymphotoxins having amino acid sequences that differ from those found in nature. The lymphotoxins are purified to a specific activity of 2-10x10 7 units/mg of protein by purification using a novel immobilized, lymphotoxin-neutralizing monoclonal antibody.

    摘要翻译: 淋巴毒素(I)从同源蛋白完全免费并在未知的数额不明的或现在是新的。 糖基化(I)是新的。 变体(I),其中在(Ⅰ)序列的氨基酸残基已缺失或substd。 被其它残基,或者在另一个残基已经被插入,是新的。 提供没有(I)亮氨酸在(+)1或His(+)23被排除具有氨基末端与一个序列。 核酸编码(I)和选自(a)选自 - (c)中是新的。 (A)DNA编码(I)从其中DNA起源生物体的DNA编码其它蛋白质的分类; (B)编码的DNA(I),从非翻译插入序列的分类; 和(c)的核酸杂交能够伊辛的酸的核酸编码(I)提供确实的酸不具有天然DNA或RNA编码(I)的核苷酸序列。